Oscar Health Inc (OSCR)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Oscar Health Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 31 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 31.20 $ — 95% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
Uses AIOscar Health nutzt KI operativ und breit im eigenen Technologie-Stack: Laut Geschäftsbericht (10-K) für 2025 sind KI-Technologien in Automatisierung (virtuelle Versorgung, Abrechnungsverarbeitung), Mitglieder-Personalisierung und digitale Self-Service-Funktionen eingebettet; 2025 startete zudem der persönliche KI-Agent „Oswell“ für Mitglieder. Eine KI-Umsatzquelle ist nicht dokumentiert (die +Oscar-Plattformerlöse sind unwesentlich), und die Risikofaktoren behandeln nur Risiken aus der eigenen KI-Nutzung — daher „Nutzt KI“.
View the full file — quotes, sources, reviewed filings
„We have embedded AI Technologies across many aspects of our technology stack, including: (i) automation to drive efficiencies in our administrative functions, including virtual care and claims processing, (ii) member personalization, to improve the quality of touchpoints members have with the healthcare ecosystem; and (iii) digital self-service and member-facing agent capabilities to facilitate care and improve the member experience."
Wir haben KI-Technologien in viele Bereiche unseres Technologie-Stacks eingebettet, darunter: (i) Automatisierung, um Effizienzgewinne in unseren Verwaltungsfunktionen zu erzielen, einschließlich virtueller Versorgung und Abrechnungsverarbeitung, (ii) Mitglieder-Personalisierung, um die Qualität der Berührungspunkte der Mitglieder mit dem Gesundheitssystem zu verbessern, und (iii) digitale Self-Service- und mitgliederorientierte Agenten-Funktionen, um die Versorgung zu erleichtern und das Mitgliedererlebnis zu verbessern.
„Our business currently utilizes AI Technologies to drive efficiencies in our business, including by deploying use cases that are designed to streamline administrative processes, improve the experience for our members and providers and enhance our decision making capabilities. We are making, and plan to make in the future, investments in adopting AI Technologies across our business and across our technology stack. For example, in 2025, we launched Oswell, a personal AI agent designed to provide our members with on-demand support and doctors with data to improve care paths."
Unser Geschäft nutzt KI-Technologien derzeit, um Effizienzgewinne zu erzielen — unter anderem mit Anwendungsfällen, die Verwaltungsprozesse verschlanken, das Erlebnis für unsere Mitglieder und Leistungserbringer verbessern und unsere Entscheidungsfähigkeit stärken sollen. Wir investieren — und planen auch künftig zu investieren — in die Einführung von KI-Technologien in unserem gesamten Geschäft und Technologie-Stack. So haben wir 2025 Oswell gestartet, einen persönlichen KI-Agenten, der unseren Mitgliedern Unterstützung auf Abruf bietet und Ärzten Daten zur Verbesserung der Behandlungspfade liefert.
„Leveraging AI enabled member and provider service touch points to provide high quality, impactful services at scale, including chatbots to answer health, wellness and insurance plan questions."
Nutzung KI-gestützter Service-Kontaktpunkte für Mitglieder und Leistungserbringer, um hochwertige, wirkungsvolle Dienste in großem Maßstab zu erbringen — einschließlich Chatbots, die Fragen zu Gesundheit, Wohlbefinden und Versicherungsplänen beantworten.
Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-08 · 10-K 2026-02-13 · 10-K 2025-02-20
Rated on July 9, 2026 · How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 19.2% below the current price.
- Consensus
- Hold
- Analyst Ratings
- 7
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1.11 | 0.75 – 1.49 | 18,573 | 165.7% | 10 |
| 12/31/2027 | 1.57 | 1.00 – 2.25 | 19,779 | 41.0% | 10 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.43 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.58 | – | 2,392 | 67.10 | -6.40 | 347 | 340 |
| 2025: Q1 | 0.90 | 49.00 | 3,046 | 42.20 | 9.00 | 879 | 870 |
| 2025: Q2 | -0.85 | -557.00 | 2,864 | 29.00 | -8.00 | 509 | 500 |
| 2025: Q3 | -0.53 | – | 2,986 | 23.20 | -4.60 | -965 | -974 |
| 2025: Q4 | -1.24 | – | 2,805 | 17.30 | -12.60 | 672 | 663 |
| 2026: Q1 | 2.06 | 128.90 | 4,647 | 52.60 | 14.60 | 2,619 | 2,610 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 554 | -259 | -261 | -9.06 | -165 | 853 | 1,347 |
| 2020 | 590 | -406 | -407 | -13.90 | 223 | -1,296 | 2,272 |
| 2021 | 1,921 | -571 | -573 | -3.20 | -182 | 1,387 | 3,322 |
| 2022 | 4,126 | -610 | -606 | -2.85 | 380 | 890 | 4,527 |
| 2023 | 5,863 | -236 | -271 | -1.22 | -272 | 804 | 3,601 |
| 2024 | 9,178 | 57 | 25 | 0.10 | 978 | 1,014 | 4,841 |
| 2025 | 11,701 | -396 | -443 | -1.69 | 1,095 | 978 | 6,325 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Oscar Health, Inc. ist als Gesundheitstechnologieunternehmen in den USA tätig.
| Employees | 2,305 |
|---|---|
| Headquarters | New York, NY |
| Address | 75 Varick Street, 10013 New York, United States |
| Phone | 646 403 3677 |
| Website | hioscar.com |
| IPO Date | 3. Mar 2021 |
| ISIN | US6877931096 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Mark Thomas Bertolini | CEO & Director | 1957 |
| Joshua Kushner | Co-Founder & Vice Chairman | 1985 |
| Mario Tobias Schlosser | Co-Founder, Advisor to the CEO & Director | 1979 |
| Richard Scott Blackley CPA | Chief Financial Officer | 1968 |
| Adam McAnaney | EVP & Chief Legal Officer | 1977 |
| Janet Ann Liang | EVP & President of Oscar Insurance | 1968 |
| Victoria Baltrus | Chief Accounting Officer | 1970 |
| Chris Potochar | Vice President of Treasury & Investor Relations | – |
| Rebecca Krouse | Chief People Officer | – |
| Joel I. Klein J.D. | Senior Advisor | 1947 |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.